Correlation Between Alnylam Pharmaceuticals and Liquidia Technologies
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Liquidia Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Liquidia Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Liquidia Technologies, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Liquidia Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Liquidia Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Liquidia Technologies.
Diversification Opportunities for Alnylam Pharmaceuticals and Liquidia Technologies
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Alnylam and Liquidia is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Liquidia Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Liquidia Technologies and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Liquidia Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Liquidia Technologies has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Liquidia Technologies go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Liquidia Technologies
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 2.24 times less return on investment than Liquidia Technologies. But when comparing it to its historical volatility, Alnylam Pharmaceuticals is 1.41 times less risky than Liquidia Technologies. It trades about 0.04 of its potential returns per unit of risk. Liquidia Technologies is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 745.00 in Liquidia Technologies on November 9, 2024 and sell it today you would earn a total of 851.00 from holding Liquidia Technologies or generate 114.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Liquidia Technologies
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Liquidia Technologies |
Alnylam Pharmaceuticals and Liquidia Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Liquidia Technologies
The main advantage of trading using opposite Alnylam Pharmaceuticals and Liquidia Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Liquidia Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Liquidia Technologies will offset losses from the drop in Liquidia Technologies' long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
| Liquidia Technologies vs. Biomarin Pharmaceutical | Liquidia Technologies vs. Vaxcyte | Liquidia Technologies vs. Legend Biotech Corp | Liquidia Technologies vs. Bio Techne Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |